Marvin Slosman, CEO and President at InspireMD, Inc. (NSPR), bought 21,000 shares at $1.20 ($25K) on 2026-05-12, disclosed to the SEC on 2026-05-13.
CEO Marvin Slosman purchased $25,200 of stock at $1.20, marking the largest insider purchase in the company's history and signaling confidence in the stock's recovery potential. The trade comes as the stock trades near a 52-week low and has recently beaten revenue estimates.
The stock is down 31.18% over the last 90 days and is currently trading 60.09% below its 52-week high of $2.93, though it has recovered slightly to trade 10.38% above its 52-week low of $1.06.
1) FDA approval for CGuard Prime TCAR expected in late 2026 per the June 16 news headline; 2) Q1 2026 earnings on May 4, 2026, where the company beat revenue estimates by 25.85%; 3) The CEO's largest-ever purchase signals a potential reversal in sentiment.
The stock is down 51.85% over the last year, indicating significant long-term underperformance despite recent quarterly beats.
Nothing distinguishes this filing.
| Filing → |